Takeda Pharmaceutical (TAK) EPS (Basic) (2017 - 2026)
Takeda Pharmaceutical's (TAK) quarterly EPS (Basic) came in at -$1.49 in Q1 2026, down 389.31% year-on-year from $0.52 in Q1 2025, and up 2.1% quarter-over-quarter from -$1.52 in Q4 2025.
Takeda Pharmaceutical (TAK) EPS (Basic) (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's EPS (Basic) history runs 10 years deep, the most recent figure standing at -$1.49 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 389.31% year-over-year to -$1.49 in Q1 2026; TTM through Mar 2026 was -$1.68, a 222.43% decrease from a year earlier, with the FY2026 full-year figure at -$0.64, down 243.23% from the prior year.
- EPS (Basic) grew to -$1.49 in Q1 2026 per TAK's latest filing, from -$1.52 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.93 in Q3 2025 and bottomed at -$1.52 in Q4 2025.
- The 5-year median for EPS (Basic) is $0.07 (2022), against an average of $0.05.
- Biggest YoY gain for EPS (Basic) was 1743.15% in 2024; the steepest drop was 3288.75% in 2024.
- Year by year, EPS (Basic) stood at $0.06 in 2022, then tumbled by 77.18% to $0.01 in 2023, then slumped by 3288.75% to -$0.43 in 2024, then plunged by 253.72% to -$1.52 in 2025, then gained by 2.1% to -$1.49 in 2026.
- Per Business Quant, the three latest TAK EPS (Basic) figures stand at -$1.49 (Q1 2026), -$1.52 (Q4 2025), and $0.93 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.32 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | -0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.49 |
| Dec 31, 2025 | -1.52 |
| Sep 30, 2025 | 0.93 |
| Jun 30, 2025 | 0.40 |
| Mar 31, 2025 | 0.52 |
| Dec 31, 2024 | -0.43 |
| Sep 30, 2024 | 0.90 |
| Jun 30, 2024 | 0.39 |
| Mar 31, 2024 | 0.41 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | 0.51 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.07 |
| Jun 30, 2022 | 0.09 |
| Mar 31, 2022 | -0.06 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | 0.04 |
| Jun 30, 2021 | 0.14 |